Citations: Widing,Line; Bechensteen,Anne Grete; Mirlashari,Mohammad Reza; Vetlesen,Annette; Kjeldsen-Kragh,Jens. Evaluation of nonleukoreduced red blood cell transfusion units collected at delivery from the placenta. Transfusion 2000;47:1481-1487. (Link)
Chan,Wai Long; Leung,Joseph; Chan,Loretta; Tam,K.; Tang,Sydney; Lai,Kar Neng. BMP-7 protects mesangial cells from injury by polymeric IgA. Kidney Int 2008;74:1026-1039. (Link)
Ayatollahi,M.; Geramizadeh,B.; Yazdani,M.; Azarpira,N.. Effect of the Immunoregulatory Cytokines on Successful Pregnancy Depends Upon the Control of Graft Rejection Mechanisms. Transplantation Proceedings 2007;39:244-245. (Link)
Vetlesen,Annette; Mirlashari,Mohammad Reza; Ezligini,Farshid; Kjeldsen-Kragh,Jens. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2006;47:126-132. (Link)
Roopa,B.A.; Loganath,Annamalai; Singh,Kuldip. The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium. Human Reproduction 2003;18:1809-1819. (Link)
Lewkowicz,N.; Lewkowicz,P.; Banasik,M.; Kurnatowska,A.; Tchorzewski,H.. Predominance of Type 1 cytokines and decreased number of CD4^+CD25^+^h^i^g^h T regulatory cells in peripheral blood of... Immunology letters 2005;99:57-62. (Link)
Bryant,Nichole L.; Suarez-Cuervo,Catalina; Gillespie,G.Yancey; Markert,James M.; Nabors,L.Burt; Meleth,Sreelatha; Lopez,Richard D.; Lamb,Lawrence S.,Jr.. Characterization and immunotherapeutic potential of {gamma}{delta} T cells in patients with glioblastoma. Neuro-Oncology 2009;15228517-2008. (Link)
Meiffren,Gregory; Flacher,Monique; Azocar,Olga; Rabourdin-Combe,Chantal; Faure,Mathias. Cutting Edge: Abortive Proliferation of CD46-Induced Tr1-Like Cells due to a Defective Akt/Survivin Signaling Pathway. The Journal of Immunology 2006;177:4957-4961. (Link)
Calder,V.L.; Bondeson,J.; Brennan,F.M.; Foxwell,B.M.J.; Feldmann,M.. Antigen-Specific T-Cell Downregulation by Human Dendritic Cells Following Blockade of NF-kappaB. Scandinavian Journal of Immunology 2003;57:261-270. (Link)
Liu,Lei; Hartwig,Dirk; Harloff,Susanne; Herminghaus,Philip; Wedel,Thilo; Kasper,Karsten; Geerling,Gerd. Corneal Epitheliotrophic Capacity of Three Different Blood-Derived Preparations. Investigative Ophthalmology & Visual Science 2006;47:2438-2444. (Link)
Pelissier,P.; Masquelet,A.C.; Bareille,R.; Mathoulin Pelissier,S.; Amedee,J.. Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone... Journal of Orthopaedic Research 2004;22:73-79. (Link)
References: Chopra,V.; Dinh,T.V.; Hannigan,E.V.. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 1998;16:152-159. (Link)
Matsubara,T.; Umezawa,Y.; Tsuru,S.; Motohashi,T.; Yabuta,K.; Furukawa,S.. Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand.J.Rheumatol. 1997;26:314-317. (Link)
Kim,J.S.; Yoon,S.S.; Kim,Y.H.; Ryu,J.S.. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 1996;27:1553-1557. (Link)
Langdahl,B.L.; Knudsen,J.Y.; Jensen,H.K.; Gregersen,N.; Eriksen,E.F.. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997;20:289-294. (Link)
Matsubara,T.; Umezawa,Y.; Tsuru,S.; Motohashi,T.; Yabuta,K.; Furukawa,S.. Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand.J Rheumatol 1997;26:314-317. (Link)
Martyre,M.C.; Magdelenat,H.; Bryckaert,M.C.; Laine-Bidron,C.; Calvo,F.. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia. Br.J Haematol. 1991;77:80-86. (Link)
Finch,C.E.; Laping,N.J.; Morgan,T.E.; Nichols,N.R.; Pasinetti,G.M.. TGF-beta 1 is an organizer of responses to neurodegeneration. J.Cell Biochem. 1993;53:314-322. (Link)
Bayer,E.M.; Herr,W.; Kanzler,S.; Waldmann,C.; Meyer Zum Buschenfelde,K.H.; Dienes,H.P.; Lohse,A.W.. Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J.Hepatol. 1998;28:803-811. (Link)
Bayer,E.M.; Herr,W.; Kanzler,S.; Waldmann,C.; Meyer Zum Buschenfelde,K.H.; Dienes,H.P.; Lohse,A.W.. Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J Hepatol. 1998;28:803-811. (Link)
Carrieri,P.B.; Provitera,V.; Bruno,R.; Perrella,M.; Tartaglia,G.; Busto,A.; Perrella,O.. Possible role of transforming growth factor-beta in relapsing-remitting multiple sclerosis. Neurol.Res. 1997;19:599-600. (Link)
Wolff,J.M.; Fandel,T.; Borchers,H.; Brehmer,B.,Jr.; Jakse,G.. Transforming growth factor-beta1 serum concentration in patients with prostatic cancer and benign prostatic hyperplasia. Br.J.Urol. 1998;81:403-405. (Link)
Lawrence,D.A.. Transforming growth factor-beta: a general review. Eur Cytokine Netw. 1996;7:363-374. (Link)
Pfeilschifter,J.; Diel,I.; Scheppach,B.; Bretz,A.; Krempien,R.; Erdmann,J.; Schmid,G.; Reske,N.; Bismar,H.; Seck,T.; Krempien,B.; Ziegler,R.. Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume. J.Bone Miner.Res. 1998;13:716-730. (Link)
Kropf,J.; Schurek,J.O.; Wollner,A.; Gressner,A.M.. Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison.. Clin.Chem. 1997;43:1965-1974. (Link)
Tornquist,S.J.; Oaks,J.L.; Crawford,T.B.. Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia. J.Gen.Virol. 1997;78 ( Pt 10:2541-2548. (Link)
Chao,C.C.; Janoff,E.N.; Hu,S.X.; Thomas,K.; Gallagher,M.; Tsang,M.; Peterson,P.K.. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991;3:292-298. (Link)
Del,Giudice G.; Crow,M.K.. Role of transforming growth factor beta (TGF beta) in systemic autoimmunity. Lupus 1993;2:213-220. (Link)
Astiz,M.; Saha,D.; Lustbader,D.; Lin,R.; Rackow,E.. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin.Med 1996;128:594-600. (Link)
Muller,F.; Aukrust,P.; Nilssen,D.E.; Froland,S.S.. Reduced serum level of transforming growth factor-beta in patients with IgA deficiency. Clin.Immunol.Immunopathol. 1995;76:203-208. (Link)
Shankland,S.J.; Johnson,R.J.. TGF-beta in glomerular disease. Miner.Electrolyte Metab 1998;24:168-173. (Link)
Mattson,M.P.; Barger,S.W.; Furukawa,K.; Bruce,A.J.; Wyss-Coray,T.; Mark,R.J.; Mucke,L.. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res.Brain Res.Rev. 1997;23:47-61. (Link)
Border,W.A.. Transforming growth factor-beta and the pathogenesis of glomerular diseases. Curr.Opin.Nephrol.Hypertens. 1994;3:54-58. (Link)
Flanders,K.C.; Ren,R.F.; Lippa,C.F.. Transforming growth factor-betas in neurodegenerative disease. Prog.Neurobiol. 1998;54:71-85. (Link)
Murawaki,Y.; Ikuta,Y.; Nishimura,Y.; Koda,M.; Kawasaki,H.. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis. J Gastroenterol.Hepatol. 1996;11:443-450. (Link)
Zauli,G.; Gugliotta,L.; Catani,L.; Vianelli,N.; Borgatti,P.; Belmonte,M.M.; Tura,S.. Increased serum levels of transforming growth factor beta-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis. Br.J.Haematol. 1993;84:381-386. (Link)
